This Pre-Solicitation opportunity from Department Of Veterans Affairs was posted on July 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
6505--Glipizide Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Department of Veterans Affairs, through the National Acquisition Center, plans to award a single indefinite-delivery, indefinite-quantity contract for Glipizide Tablets to ensure an uninterrupted supply for VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center facilities. The contract will have a one-year base period with four one-year option periods, and the product will be distributed via the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under a unique NDC number assigned exclusively to them, with their label being the only label on the product; VA labeling must be able to securely adhere over the contractor’s label without overlapping or covering existing labels. All tablets must be packaged in unit-of-use bottles with specific physical requirements: cylindrical shape, minimum 120cc volume, 5.75-inch circumference, and a label space of 5.25 x 2 inches with an additional 0.5 inches reserved for barcodes and expiration dates. Bottles must include a safety cap that can be converted to a non-safety cap and must not exceed the bottle’s diameter. The solicitation will be issued electronically on or about July 27, 2026, with responses due by August 10, 2026, under FAR Part 12 as a commercial item procurement. The NAICS code is 325412, and only electronic access via SAM.gov is available—no paper copies or phone requests will be honored. Estimated annual demand includes multiple package sizes for both 5mg and 10mg tablets, with bottle volumes of 90, 180, and 360 counts for unit-of-use packaging, and bulk options of 500 or 1,000 tablets for non-unit-of-use needs, totaling over 300,000 bottles annually. The primary point of contact is Contract Specialist Deb Fassl, reachable via email at Deborah.Fassl@va.gov, and potential offerors must monitor SAM.gov regularly for amendments or updates. All responsible sources are invited to submit offers, and submissions received on time will be considered without restriction.
General Info
Agency
NAICS
Place of Performance
ILSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
REQUIREMENT DESCRIPTION ITEM DESCRIPTION UNIT of USE
PKG. SIZE (Tablets per Bottle) TOTAL EST. ANNUAL USAGE (Bottles) 1 GLIPIZIDE 5MG TAB Y 90 60,691 2 GLIPIZIDE 5MG TAB Y 180 58,708 3a GLIPIZIDE 5MG TAB N 500 50,084 OR 3b GLIPIZIDE 5MG TAB N 1000 25,042 4 GLIPIZIDE 10MG TAB Y 90 26,156 5 GLIPIZIDE 10MG TAB Y 180 88,612 6 GLIPIZIDE 10MG TAB Y 360 18,238 7a GLIPIZIDE 10MG TAB N 500 57,870 OR 7b GLIPIZIDE 10MG TAB N 1000 28,935
More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
